title: Optimal duration of anticoagulation after venous thromboembolism.
authors.affiliation: Venous Thromboembolism Research Group, Cardiovascular Medicine Division, Brigham and Women's Hospital, Boston, MA 02115, USA. sgoldhaber@partners.org
authors.forename: Samuel Z
authors.initials: SZ
authors.lastname: Goldhaber
authors.forename: Gregory
authors.initials: G
authors.lastname: Piazza
mesh_terms: D000368:Aged; D000532:Altitude Sickness / Q000150:complications; D000925:Anticoagulants / Q000627:therapeutic use*; D008076:Cholesterol, HDL / Q000097:blood; D002986:Clinical Trials as Topic; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications; D011152:Popliteal Vein / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000209:etiology; D012307:Risk Factors; D012737:Sex Factors; D014463:Ultrasonography; D054556:Venous Thromboembolism / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000925:Anticoagulants; D008076:Cholesterol, HDL; D017984:Enoxaparin; D014859:Warfarin